Parathyroid Hormone-related Protein

DRUG2 trials

Sponsors

University of Pittsburgh

Conditions

OsteoporosisOsteoporosis, Postmenopausal

Phase 1

PTHrP(1-36) IV Dose Escalation Study

WithdrawnNCT00177411

University of PittsburghOsteoporosis

Start: 2005-07-31End: 2007-07-31Updated: 2014-09-05

3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women

CompletedNCT00222872

University of PittsburghOsteoporosis, Osteoporosis, Postmenopausal

Start: 2005-07-31End: 2008-09-30Updated: 2014-04-28